Langston Robert D, Presley Rodney, Flanders W Dana, McClellan William M
Georgia Medical Care Foundation, Atlanta, Georgia 30346, USA.
Kidney Int. 2003 Oct;64(4):1398-405. doi: 10.1046/j.1523-1755.2003.00200.x.
Chronic kidney disease (CKD) increases risk of death among patients with coronary artery disease. Mortality risks associated with CKD among patients with cardiovascular disease (CVD) are not well defined. Anemia is associated with increased mortality in end-stage renal disease (ESRD) patients and may also increase risk among patients with CVD.
A random sample of patients admitted to the hospital in a single southern state with a principal diagnosis of acute myocardial infarction (ICD-9 codes 410.xx) were followed up after hospital discharge.
CKD was found in 60% of the cohort. Hematocrit of >or=40 was found in 46% of the patients; 26.0% had a hematocrit between 36% and 39%, 21.8% between 30% and 35%, and 5.9% had a hematocrit of less than 30%. The 1-year death rates among individuals with and without CKD were 31.7% and 10.4% respectively [odds ratio (OR) = 4.00 (2.34, 6.91)]. The mortality at one year was 18.6% for individuals with a hematocrit greater than or equal to 40%; 23.5% (OR = 1.35; 95% CI = 0.78, 2.32) for hematocrit 36% to 39%; 30.7% (OR = 1.94; 95% CI = 1.12, 3.34) for hematocrit between 30% and 35%; and 35.8% (OR = 3.16; 95% CI = 1.35, 7.40) for those with a hematocrit less than 30% (chi2 for trend was 12.2, P = 0.007). Both hematocrit and serum creatinine were independently associated with increased risk of death during follow-up after controlling for other patient risk factors.
CKD and decreasing hematocrit were frequent among older patients hospitalized for acute myocardial infarction and are independent predictors of subsequent risk of death.
慢性肾脏病(CKD)会增加冠状动脉疾病患者的死亡风险。心血管疾病(CVD)患者中与CKD相关的死亡风险尚未明确界定。贫血与终末期肾病(ESRD)患者死亡率增加相关,也可能增加CVD患者的风险。
对美国南部一个州一家医院收治的主要诊断为急性心肌梗死(国际疾病分类第九版编码410.xx)的患者进行随机抽样,并在出院后进行随访。
该队列中60%的患者患有CKD。46%的患者血细胞比容≥40%;26.0%的患者血细胞比容在36%至39%之间,21.8%的患者血细胞比容在30%至35%之间,5.9%的患者血细胞比容低于30%。患有和未患有CKD的个体1年死亡率分别为31.7%和10.4%[比值比(OR)=4.00(2.34,6.91)]。血细胞比容大于或等于40%的个体1年死亡率为18.6%;血细胞比容为36%至39%的个体死亡率为23.5%(OR = 1.35;95%置信区间 = 0.78,2.32);血细胞比容在30%至35%之间的个体死亡率为30.7%(OR = 1.94;95%置信区间 = 1.12,3.34);血细胞比容低于30%的个体死亡率为35.8%(OR = 3.16;95%置信区间 = 1.35,7.40)(趋势卡方检验为12.2,P = 0.007)。在控制其他患者风险因素后,血细胞比容和血清肌酐均与随访期间死亡风险增加独立相关。
因急性心肌梗死住院的老年患者中CKD和血细胞比容降低很常见,且是后续死亡风险的独立预测因素。